Current Issue
Editorial Message and Issue Highlights–Vol. 17, No. 1–3, January–March 2020
Dear Colleagues: Welcome to the January–March 2020 edition of Innovations in Clinical Neuroscience (ICNS). I’d first like to inform our readers that starting this year, ICNS will move from a six-times-per-year frequency to four times a year. However, while you will be receiving a complete issue of ICNS less frequently than in years past, we […]
Subependymal Giant-cell Astrocytoma Masquerading as Restrictive Eating Disorder and Depression in an Adolescent
by Alicia Barnes, DO, MPH; Maggie M. Wang, BS; Jordan Feltes, BS; Je Ko, MD, PhD; and Miguel A. Guzman, MD Drs. Barnes and Ko are with the Department of Psychiatry, Saint Louis University School of Medicine in St. Louis, Missouri. Ms. Wang and Feltes are with the Saint Louis University School of Medicine in […]
Innovative Approaches for Slowing Disease Progression in Parkinson’s Disease: Takeaways from the 14th Annual International Society for Central Nervous System Clinical Trials and Methodology Scientific Meeting
by Monica Javidnia, PhD; Mark Frasier, PhD; Ira Shoulson, MD; Ibrahim Turkoz, PhD; and Kumar Budur, MD, MS Drs. Javidnia and Shoulson are with the Center for Health + Technology and the Department of Neurology, University of Rochester Medical Center in Rochester, New York. Dr. Shoulson is also with Grey Matter Technologies in Sarasota, Florida. […]
Psychotherapy with Survivors of Sexual Abuse and Assault
by Allison Cowan, MD and Ali Ashai, MD Drs. Cowan and Ashai are with the Department of Psychiatry at the Boonshoft School of Medicine at Wright State University in Dayton, Ohio. FUNDING: No funding was provided. DISCLOSURES: The authors have no conflicts of interest relevant to the content of this article. ABSTRACT: Sexual assault and […]
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?
by David G. Daniel, MD; Alan Kott, MD; Jay Saoud, Phd; Remy Luthringer, PhD; Vadym Rud, MD, PhD; Andrii Skyrpnikov, MD, PhD; Rodica Stan, MD, PhD; Veselin Palazov, MD; Xingmei Wang, MS; and Michael Davidson, MD Dr. Daniel is with Signant Health in Mclean, Virginia. Dr. Kott is with Signant Health in Prague, the Czech […]
Psychiatric Symptoms in Cushing’s Syndrome: A Systematic Review
by Tiffany Y. Lin, MD; Jasmine Hanna; and Waguih William IsHak, MD, FAPA Drs. Lin and Ishak are with the David Geffen School of Medicine at UCLA in Los Angeles, California. Dr. Ishak is also with the Department of Psychiatry & Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles, California. Ms. Hanna is a […]
The Effects of Paliperidone Palmitate 1 Month on the Employment Status and Social Functioning of Patients with Schizophrenia
by Takashi Ohnishi, MD, PhD; Hisanori Kobayashi, PhD; Toshio Yamaoka; Tokiko Toma; Keiko Imai; Akihide Wakamatsu; and Kenichi Noguchi, PhD Drs. Ohnishi, Kobayashi, and Noguchi and Mr. Wakamatsu are with the Medical Affairs Division of Janssen Pharmaceutical K.K. in Tokyo, Japan. Mr. Yamaoka, Ms. Toma, and Ms. Imai are with the Drug Safety Surveillance Department, […]
Use of Mixed Amphetamine Salts in a Patient with Depersonalization/Derealization Disorder
by Samuel R. Weber, MD Dr. Weber is with Intermountain Healthcare in Logan, Utah. FUNDING: No funding was provided for this study. DISCLOSURES: The author has no conflicts of interest relevant to the content of this article. ABSTRACT: Depersonalization and derealization symptoms are common and often transient. Recurrent, persistent symptoms can result in a diagnosis […]
Navigating the ADA: What Clinicians Need to Know—Part Two
by Donna Vanderpool, MBA, JD Ms. Vanderpool is the Vice President of Risk Management at Professional Risk Management Services in Arlington, Virginia. FUNDING: No funding was provided for the preparation of this article. DISCLOSURES: The author is an employee of PRMS Inc., a risk-management consulting company for healthcare providers. This ongoing column is dedicated to […]
Donkey Therapy and Hippotherapy: Two Faces of the Same Coin?
by Simona Portaro, MD, PhD; Giuseppa Maresca, PsyD; Antonio Raffa, MSc; Gaetano Gemelli; Barbara Aliberti; and Rocco Salvatore Calabrò, MD, PhD Dr. Portaro, Dr. Maresca, Mr. Raffa, and Dr. Calabrò are with IRCCS Centro Neurolesi “Bonino Pulejo” in Messina, Italy. Mr. Gemelli and Ms. Aliberti are with THES ASD in Milazzo, ME, Italy. FUNDING: No […]
Continue Reading